Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methanol | HCID 887 | — |
| Reactant | 4'-Chlorobiphenyl-2-carbaldehyde | HCID 1393689 | — |
| Reactant | Sodium cyanoborohydride | HCID 5003444 | — |
| Reactant | HCID 67980541 | HCID 67980541 | — |
| Catalyst | Zincchloride | HCID 3007855 | — |
| Product | Trifluoroacetic acid | HCID 6422 | 18% |
| Product | HCID 86667201 | HCID 86667201 | — |
Reaction Steps
To a vial containing N-[7-(2-methyl-piperidin-4-yl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]-4-((R)-3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-3-trifluoro methanesulfonyl-benzenesulfonamide (20 mg, 0.026 mmol), 4′-chloro-biphenyl-2-carbaldehyde (16.82 mg, 0.078 mmol) and zinc chloride (3.53 mg, 0.034 mol) was added methanol (1 mL) under nitrogen and the mixture was stirred for 10 minutes. Sodium cyanoborohydride (13.01 mg, 0.207 mmol) was then added, and the reaction was stirred at ambient temperature for 14 hours. The reaction mixture was then concentrated and partitioned between ethyl acetate and 2 M NaOH. The aqueous layer was extracted three times with EtOAc. The combined organic layers were washed with 1M NaOH, dried under Na2SO4, filtered and concentrated under reduced pressure. The crude material was purified via HPLC (0.1% TFA Modifier in water in MeCN) to afford the title compound as a TFA salt (5 mg, 18% yield).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08809352B2 |
|---|
| Source dataset | uspto-grants-2014_08 |
|---|
| ORD ID | ord-8ff4f92e0319485c8e98ee90ae7e1f81 |
|---|
| Source note | uspto-grants-2014_08 |
|---|